Clinical Characteristics and Prognosis Associated with Multiple Primary Cancers in Breast Cancer Patients

Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the character...

Full description

Saved in:
Bibliographic Details
Published inJournal of breast cancer Vol. 21; no. 1; pp. 62 - 69
Main Authors Kim, Bong Kyun, Oh, Se Jeong, Song, Jeong-Yoon, Lee, Han-Byoel, Park, Min Ho, Jung, Yongsik, Park, Woo-Chan, Lee, Jina, Sun, Woo Young
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Breast Cancer Society 01.03.2018
한국유방암학회
Subjects
Online AccessGet full text
ISSN1738-6756
2092-9900
DOI10.4048/jbc.2018.21.1.62

Cover

Abstract Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs). Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis. Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis. MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer.
AbstractList Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs). Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis. Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis. MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer.
Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs).PURPOSEBreast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs).Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis.METHODSData from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis.Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis.RESULTSAmong the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis.MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer.CONCLUSIONMPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer.
Purpose: Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs). Methods: Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis. Results: Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis. Conclusion: MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer. KCI Citation Count: 13
Author Oh, Se Jeong
Jung, Yongsik
Park, Woo-Chan
Sun, Woo Young
Lee, Han-Byoel
Park, Min Ho
Kim, Bong Kyun
Lee, Jina
Song, Jeong-Yoon
AuthorAffiliation 1 Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
6 Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
5 Department of Surgery, Ajou University School of Medicine, Suwon, Korea
Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea
2 Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea
4 Department of Surgery, Chonnam National University Medical School, Gwangju, Korea
3 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: 4 Department of Surgery, Chonnam National University Medical School, Gwangju, Korea
– name: 5 Department of Surgery, Ajou University School of Medicine, Suwon, Korea
– name: 6 Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
– name: 1 Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
– name: 3 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
– name: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea
– name: 2 Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Bong Kyun
  surname: Kim
  fullname: Kim, Bong Kyun
  organization: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea
– sequence: 2
  givenname: Se Jeong
  surname: Oh
  fullname: Oh, Se Jeong
  organization: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
– sequence: 3
  givenname: Jeong-Yoon
  surname: Song
  fullname: Song, Jeong-Yoon
  organization: Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea
– sequence: 4
  givenname: Han-Byoel
  surname: Lee
  fullname: Lee, Han-Byoel
  organization: Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Min Ho
  surname: Park
  fullname: Park, Min Ho
  organization: Department of Surgery, Chonnam National University Medical School, Gwangju, Korea
– sequence: 6
  givenname: Yongsik
  surname: Jung
  fullname: Jung, Yongsik
  organization: Department of Surgery, Ajou University School of Medicine, Suwon, Korea
– sequence: 7
  givenname: Woo-Chan
  surname: Park
  fullname: Park, Woo-Chan
  organization: Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
– sequence: 8
  givenname: Jina
  surname: Lee
  fullname: Lee, Jina
  organization: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea
– sequence: 9
  givenname: Woo Young
  surname: Sun
  fullname: Sun, Woo Young
  organization: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29628985$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002327984$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kc1v1DAQxS3Uim4Ld07IRzgkHX8nF6Ql4qNSERUqZ8txnK7brL3Y3lb892S7SwVInEaa-b03Y79TdBRicAi9IlBz4M35bW9rCqSpKalJLekztKDQ0qptAY7QgijWVFIJeYJOc74FkJwp9Ryd0FbSpm3EAvlu8sFbM-FuZZKxxSWfi7cZmzDgqxRvQsw-42XO0XpT3IAffFnhL9up-M3kZsSvTfqJOxOsSxn7gN8nZ3I5dPCVKd6Fkl-g49FM2b081DP0_eOH6-5zdfn100W3vKwsZ1AqIhXvpaJ8ZGNLmW0YI4aSvhVmoD0XfaP4qABGEFQCHcHYnvdmIFxwJRiwM_R27xvSqO-s19H4x3oT9V3Sy2_XF5qBFIq2M_tuz262_doNdr4zmUlv9m96VP49CX41-9xr0TTQSjUbvDkYpPhj63LRa5-tmyYTXNxmTYEyTghjdEZf_7nracnvLGYA9oBNMefkxieEgN7Free49S5uTYkmWu485T8S68v833F3rZ_-L_wFr52v6A
CitedBy_id crossref_primary_10_1038_s41598_023_30812_8
crossref_primary_10_1002_prm2_12122
crossref_primary_10_1097_CM9_0000000000001969
crossref_primary_10_1021_acssensors_4c02246
crossref_primary_10_12677_ACM_2022_124490
crossref_primary_10_12998_wjcc_v10_i34_12678
crossref_primary_10_1007_s10147_019_01430_0
crossref_primary_10_1002_cam4_4351
crossref_primary_10_54097_ijbls_v2i3_8648
crossref_primary_10_12998_wjcc_v11_i7_1513
crossref_primary_10_2147_BCTT_S321390
crossref_primary_10_7717_peerj_13528
crossref_primary_10_1515_biol_2022_0465
crossref_primary_10_16956_jes_2020_20_4_88
crossref_primary_10_3389_fonc_2022_840431
crossref_primary_10_1007_s10549_021_06122_w
crossref_primary_10_1111_ijcp_14663
Cites_doi 10.3322/caac.21412
10.4143/crt.2013.215
10.1186/1471-2407-12-138
10.3322/caac.21262
10.14735/amko201411
10.1158/1055-9965.EPI-06-0782
10.1007/978-1-59745-416-2_5
10.1089/thy.2016.0655
10.1371/journal.pone.0185485
10.3349/ymj.2015.56.5.1213
10.1177/000313480807400806
10.3343/alm.2016.36.5.463
10.1097/MD.0000000000003299
10.1093/jnci/dju289
10.7314/APJCP.2015.16.12.4921
10.1159/000447348
10.1158/1055-9965.EPI-15-0833
10.18632/oncotarget.9547
10.1056/NEJMoa050518
10.4048/jbc.2017.20.1.1
10.1177/147323001103900237
10.1111/j.1349-7006.2012.02254.x
10.7326/0003-4819-152-7-201004060-00009
10.1016/j.prp.2017.01.003
10.1016/S1470-2045(11)70061-4
10.4048/jbc.2016.19.1.1
10.1002/cncr.30248
ContentType Journal Article
Copyright 2018 Korean Breast Cancer Society 2018 Korean Breast Cancer Society
Copyright_xml – notice: 2018 Korean Breast Cancer Society 2018 Korean Breast Cancer Society
CorporateAuthor Korean Breast Cancer Society
CorporateAuthor_xml – name: Korean Breast Cancer Society
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4048/jbc.2018.21.1.62
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2092-9900
EndPage 69
ExternalDocumentID oai_kci_go_kr_ARTI_3065729
PMC5880967
29628985
10_4048_jbc_2018_21_1_62
Genre Journal Article
GrantInformation_xml – fundername: ;
– fundername: ;
  grantid: HI14C1062
GroupedDBID ---
5-W
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
DU5
EF.
GROUPED_DOAJ
HYE
KQ8
M48
O5R
O5S
PGMZT
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c430t-1674b6724f3f923c8331a21b95ad2b45b874f700f052602f0acb4bad145475303
IEDL.DBID M48
ISSN 1738-6756
IngestDate Tue Nov 21 21:39:36 EST 2023
Thu Aug 21 18:21:43 EDT 2025
Fri Jul 11 06:25:11 EDT 2025
Thu Jan 02 22:55:00 EST 2025
Tue Jul 01 01:56:43 EDT 2025
Thu Apr 24 23:11:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Multiple primary neoplasms
Breast neoplasms
Prognosis
Survival
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c430t-1674b6724f3f923c8331a21b95ad2b45b874f700f052602f0acb4bad145475303
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
https://ejbc.kr/search.php?where=aview&id=10.4048/jbc.2018.21.1.62&code=0096JBC&vmode=FULL
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4048/jbc.2018.21.1.62
PMID 29628985
PQID 2023411332
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_3065729
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5880967
proquest_miscellaneous_2023411332
pubmed_primary_29628985
crossref_primary_10_4048_jbc_2018_21_1_62
crossref_citationtrail_10_4048_jbc_2018_21_1_62
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-03-01
PublicationDateYYYYMMDD 2018-03-01
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of breast cancer
PublicationTitleAlternate J Breast Cancer
PublicationYear 2018
Publisher Korean Breast Cancer Society
한국유방암학회
Publisher_xml – name: Korean Breast Cancer Society
– name: 한국유방암학회
References Arjunan (10.4048/jbc.2018.21.1.62_ref12) 2016; 10
Romaniuk (10.4048/jbc.2018.21.1.62_ref11) 2017; 213
Berry (10.4048/jbc.2018.21.1.62_ref4) 2005; 353
Mariotto (10.4048/jbc.2018.21.1.62_ref6) 2007; 16
Gursel (10.4048/jbc.2018.21.1.62_ref19) 2011; 39
Yoshimoto (10.4048/jbc.2018.21.1.62_ref22) 1985; 15
Silva-Vieira (10.4048/jbc.2018.21.1.62_ref28) 2017; 27
Shan (10.4048/jbc.2018.21.1.62_ref9) 2017; 12
Nielsen (10.4048/jbc.2018.21.1.62_ref27) 2016; 25
Mai (10.4048/jbc.2018.21.1.62_ref24) 2016; 122
DeSantis (10.4048/jbc.2018.21.1.62_ref3) 2017; 67
Choi (10.4048/jbc.2018.21.1.62_ref15) 2016; 95
Kim (10.4048/jbc.2018.21.1.62_ref7) 2015; 47
Albright (10.4048/jbc.2018.21.1.62_ref16) 2012; 12
Eliyatkin (10.4048/jbc.2018.21.1.62_ref8) 2015; 16
Kikuchi (10.4048/jbc.2018.21.1.62_ref25) 2013; 33
Bu-Ali (10.4048/jbc.2018.21.1.62_ref10) 2008; 74
Tabuchi (10.4048/jbc.2018.21.1.62_ref21) 2012; 103
Soerjomataram (10.4048/jbc.2018.21.1.62_ref17) 2009; 471
Henderson (10.4048/jbc.2018.21.1.62_ref29) 2010; 152
Lee (10.4048/jbc.2018.21.1.62_ref20) 2015; 56
Park (10.4048/jbc.2018.21.1.62_ref23) 2016; 36
Park (10.4048/jbc.2018.21.1.62_ref14) 2017; 20
Berrington (10.4048/jbc.2018.21.1.62_ref26) 2011; 12
Munoz (10.4048/jbc.2018.21.1.62_ref5) 2014; 106
Torre (10.4048/jbc.2018.21.1.62_ref1) 2015; 65
Min (10.4048/jbc.2018.21.1.62_ref2) 2016; 19
Castro (10.4048/jbc.2018.21.1.62_ref13) 2016; 9
Koubková (10.4048/jbc.2018.21.1.62_ref18) 2014; 27
Zhang (10.4048/jbc.2018.21.1.62_ref30) 2016; 7
References_xml – volume: 67
  start-page: 439
  year: 2017
  ident: 10.4048/jbc.2018.21.1.62_ref3
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21412
– volume: 47
  start-page: 64
  year: 2015
  ident: 10.4048/jbc.2018.21.1.62_ref7
  publication-title: Cancer Res Treat
  doi: 10.4143/crt.2013.215
– volume: 12
  start-page: 138
  year: 2012
  ident: 10.4048/jbc.2018.21.1.62_ref16
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-12-138
– volume: 65
  start-page: 87
  year: 2015
  ident: 10.4048/jbc.2018.21.1.62_ref1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21262
– volume: 27
  start-page: 11
  year: 2014
  ident: 10.4048/jbc.2018.21.1.62_ref18
  publication-title: Klin Onkol
  doi: 10.14735/amko201411
– volume: 16
  start-page: 566
  year: 2007
  ident: 10.4048/jbc.2018.21.1.62_ref6
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-06-0782
– volume: 471
  start-page: 85
  year: 2009
  ident: 10.4048/jbc.2018.21.1.62_ref17
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-59745-416-2_5
– volume: 27
  start-page: 1068
  year: 2017
  ident: 10.4048/jbc.2018.21.1.62_ref28
  publication-title: Thyroid
  doi: 10.1089/thy.2016.0655
– volume: 12
  start-page: e0185485
  year: 2017
  ident: 10.4048/jbc.2018.21.1.62_ref9
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0185485
– volume: 56
  start-page: 1213
  year: 2015
  ident: 10.4048/jbc.2018.21.1.62_ref20
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2015.56.5.1213
– volume: 15
  start-page: 191
  issue: Suppl 1
  year: 1985
  ident: 10.4048/jbc.2018.21.1.62_ref22
  publication-title: Jpn J Clin Oncol
– volume: 74
  start-page: 702
  year: 2008
  ident: 10.4048/jbc.2018.21.1.62_ref10
  publication-title: Am Surg
  doi: 10.1177/000313480807400806
– volume: 10
  start-page: XD03
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref12
  publication-title: J Clin Diagn Res
– volume: 36
  start-page: 463
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref23
  publication-title: Ann Lab Med
  doi: 10.3343/alm.2016.36.5.463
– volume: 95
  start-page: e3299
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref15
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000003299
– volume: 106
  start-page: dju289
  year: 2014
  ident: 10.4048/jbc.2018.21.1.62_ref5
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dju289
– volume: 16
  start-page: 4921
  year: 2015
  ident: 10.4048/jbc.2018.21.1.62_ref8
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2015.16.12.4921
– volume: 33
  start-page: 3891
  year: 2013
  ident: 10.4048/jbc.2018.21.1.62_ref25
  publication-title: Anticancer Res
– volume: 9
  start-page: 387
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref13
  publication-title: Case Rep Oncol
  doi: 10.1159/000447348
– volume: 25
  start-page: 231
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref27
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-15-0833
– volume: 7
  start-page: 52450
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref30
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9547
– volume: 353
  start-page: 1784
  year: 2005
  ident: 10.4048/jbc.2018.21.1.62_ref4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa050518
– volume: 20
  start-page: 1
  year: 2017
  ident: 10.4048/jbc.2018.21.1.62_ref14
  publication-title: J Breast Cancer
  doi: 10.4048/jbc.2017.20.1.1
– volume: 39
  start-page: 667
  year: 2011
  ident: 10.4048/jbc.2018.21.1.62_ref19
  publication-title: J Int Med Res
  doi: 10.1177/147323001103900237
– volume: 103
  start-page: 1111
  year: 2012
  ident: 10.4048/jbc.2018.21.1.62_ref21
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2012.02254.x
– volume: 152
  start-page: 444
  year: 2010
  ident: 10.4048/jbc.2018.21.1.62_ref29
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-152-7-201004060-00009
– volume: 213
  start-page: 574
  year: 2017
  ident: 10.4048/jbc.2018.21.1.62_ref11
  publication-title: Pathol Res Pract
  doi: 10.1016/j.prp.2017.01.003
– volume: 12
  start-page: 353
  year: 2011
  ident: 10.4048/jbc.2018.21.1.62_ref26
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(11)70061-4
– volume: 19
  start-page: 1
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref2
  publication-title: J Breast Cancer
  doi: 10.4048/jbc.2016.19.1.1
– volume: 122
  start-page: 3673
  year: 2016
  ident: 10.4048/jbc.2018.21.1.62_ref24
  publication-title: Cancer
  doi: 10.1002/cncr.30248
SSID ssj0064377
Score 2.2316551
Snippet Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in...
Purpose: Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 62
SubjectTerms Original
일반외과학
Title Clinical Characteristics and Prognosis Associated with Multiple Primary Cancers in Breast Cancer Patients
URI https://www.ncbi.nlm.nih.gov/pubmed/29628985
https://www.proquest.com/docview/2023411332
https://pubmed.ncbi.nlm.nih.gov/PMC5880967
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002327984
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Breast Cancer, 2018, 21(1), 85, pp.62-69
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwELVYLlwQiK0slUFcOCTYjrP0hKACARKIA5W4WXbiQGiVQlIk-HtmkrS0qHCKlDi27PEyzzPzhpBjw2wQWo1-OiJ0MJbRMcLXDk8x6hIAgqlyA97dB9c9efvkP_2ERzcDWM6FdphPqlcM3M_3rzNY8KC_uhJpZ18NchHyyBXc5S5uyMuVtQgd-eTEpoAWqirVSghLHNTkxmg5twakCO4EgEUwxfLUebWYF-k8VfS3R-XUEXW1RlYb3ZKe15NhnSzYfINkDfPngHZnuZmpzhP6UAzR0y4r6VhONqF4N0vvGk9DKFLxUdAuzo-ipFlOL9CTfdS8oQ81NWu5SXpXl4_da6fJr-DE0mMjBwMQTBAKmXop6Hlx5HlcC246vk6Ekb6JQpmGjKXICcNEynRspNEJRxIwH86-LbKUD3O7Q2hkWaIBa2oZJNIyHVljjPVYJ018jF5tkdPxKKq4IR_HHBgDBSAERaBABApFoARXXAWiRU4mf7zVHf2n7BEIRvXjTCFbNj6fh6pfKMAENwpAkQ8QokUOx3JTsITQLqJzO_woFWaQlxzAOlS0Xctx0uR4GrRIOCPhSQFscPZLnr1UNN0-bI2dINz9s849soK9qD3a9snSqPiwB6DijEy7uhpoV_P3G3Wd9yY
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Characteristics+and+Prognosis+Associated+with+Multiple+Primary+Cancers+in+Breast+Cancer+Patients&rft.jtitle=Journal+of+breast+cancer&rft.au=Kim%2C+Bong+Kyun&rft.au=Oh%2C+Se+Jeong&rft.au=Song%2C+Jeong-Yoon&rft.au=Lee%2C+Han-Byoel&rft.date=2018-03-01&rft.issn=1738-6756&rft.volume=21&rft.issue=1&rft.spage=62&rft_id=info:doi/10.4048%2Fjbc.2018.21.1.62&rft_id=info%3Apmid%2F29628985&rft.externalDocID=29628985
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6756&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6756&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6756&client=summon